New Delhi: The registration for COVID-19 vaccination on the co-Win portal was reportedly scheduled to start on Wednesday (April 28, 2021) at midnight, however has not gone reside yet. As of seven AM, whereas registering for vaccination, it reveals -> Registration is open solely for people with age 45 years or older (start 12 months 1976 or earlier).
While the helpline number (+91-11-23978046) stays busy, the toll-free number (1075) is not working.Â
Though it’s not clear yet as to when the registration course of will start, some media stories mentioned that it’s possible to start at 4 PM right now.
Meanwhile, memes have began approaching social media platforms.Â
Waiting for registrations on #CoWin to start … pic.twitter.com/RYOmWKXeU3
— Srinath | (@SrinathNagella) April 27, 2021
18+ People ready to register their COVID-19 shot on #CoWin :#CowinApp pic.twitter.com/xA9QYWMuOg
— pratik godhani (@pgodhani) April 27, 2021
#CoWIN vaccine Reg. not yet open for 18+
govt. be like- pic.twitter.com/yRfTo3Dqgk— Deepanshu Bansal (@deepanshub786) April 27, 2021
This is to be famous that the central authorities has prolonged the COVID-19 vaccination drive to everybody above the age of 18 from May 1.Â
Phase-I used to be launched on January 16, 2021, which prioritized the safety of the Health Care Workers (HCWs) and Front Line Workers (FLWs). Subsequently, phase-II was initiated from March 1 and April 1, which targeted on defending essentially the most weak, ie, everybody above 45 years of age.
In India, the Emergency Use Authorisation has up to now been granted to two indigenously manufactured vaccines – COVISHEILD of Serum Institute of India and COVAXIN of Bharat Biotech, On the opposite hand, a 3rd vaccine, Sputnik, which is presently manufactured overseas, will finally be manufactured in India.
The Serum Institute of India COVID-19 vaccine COVISHEILD might be out there for Rs 400/dose in State Government hospitals, whereas, Bharat Biotech’s COVID-19 vaccine COVAXIN will price you Rs 600 per dose in State Government hospitals.Â
Â